Maneesh Dave, M.D., M.P.H.

Maneesh Dave, M.D., M.P.H.



Inflammatory Bowel Disease


Internal Medicine


  • Associate Professor, Department of Internal Medicine, Division of Gastroenterology


To see if Maneesh Dave is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

UC Davis Midtown Ambulatory Care Center

3160 Folsom Blvd, Suite 3500
Sacramento, CA 95816
Driving Directions

Primary Phone:

Additional Phone Numbers

Clinic Phone: 916-734-8616
Clinic Fax: 916-734-0804
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Dave is an effective listener and a committed physician. He believes in understanding individual needs of a patient and provides holistic care to them. His practice includes collaboration with pathologists, radiologists, colorectal surgeons, dieticians, and other healthcare professionals, to ensure long-term well-being of his patients.

Clinical Interests

Dr. Dave is a seasoned Gastroenterologist with expertise in Endoscopic procedures and Inflammatory Bowel Diseases (IBD) - Crohn's disease and ulcerative colitis. He uses latest advances and novel therapeutics in regenerative medicine, radiology, genetics, diet, and microbiome, to provide a personalized precision medicine approach to his IBD patients.

Research/Academic Interests

Dr. Dave's research interests are in Inflammatory Bowel Disease (IBD). His extensive research providing innovative ideas to IBD pathogenesis and treatment, has been supported by many prestigious institutions such as National Institute of Health, Crohn's and Colitis Foundation, Congressionally Directed Medical Research Programs funded by Department of Defense, Tri-Institutional (UCSF, UC Berkley, and UC Davis) Partnerships in Microbiome Research, and UC Davis Institute for Regenerative Cures. His work has been published in notable journals such as Gut, Gastroenterology, American Journal of Gastroenterology, Inflammatory Bowel Diseases, Clinical Gastroenterology and Hepatology. Dr. Dave's laboratory research program at UC Davis focuses on regenerative medicine, microbiome studies, clinical trials, and developing next-generation tools that can predict/assess response to IBD therapies. He has assembled a team of highly accomplished and senior scientific researchers, and collaborators to advance his IBD related projects. 


Gastroenterology and Hepatology

Center/Program Affiliation

UC Davis Medical Group


M.D., Topiwala National Medical College, Mumbai, India 2004

M.P.H., Molecular Epidemiology, University of Michigan, Ann Arbor MI 2007

Internship: Internal Medicine, Wayne State University School of Medicine, Detroit MI 2007-2008


Internal Medicine, Wayne State University School of Medicine, Detroit MI 2008-2010


Gastroenterology and Hepatology, Mayo Clinic, Rochester MN 2010-2014

Board Certifications

American Board of Internal Medicine,

American Board of Internal Medicine, Gastroenterology and Hepatology,

Professional Memberships

American College of Gastroenterology

American Gastroenterological Association

American Society for Gastrointestinal Endoscopy

Crohn's and Colitis Foundation

International Society for Stem Cell Research

Honors and Awards

Best Poster Award at UC Davis Liver Research Day, 2019

The American Society for Clinical Investigation - Young Physician-Scientist award, 2019

Basic Science travel award for podium presentation at the United European Gastroenterology Week, Vienna, 2018

Editorial Board member, Inflammatory Bowel Diseases Journal, 2017

Early Stage Investigator Award at Digestive Disease Week, San Diego, for podium presentation, 2016

Honorable mention "J. Arnold Bargen Award" for academic productivity at Mayo Clinic, 2013

GI fellows extramural award from Inflammatory Bowel Diseases Working Group, 2012

American Gastroenterology Association GI Fellow Travel Award, 2012

American College of Gastroenterology/AstraZeneca Gastroenterology Fellow Abstract Award for Top 10 Abstracts, 2011

First prize in oral research presentation at Internal Medicine Research Day, Wayne State University, 2008

Select Recent Publications

To see a full list of publications for Dr. Maneesh Dave, please click here.

Weissman S, Sinh P, Mehta TI, Thaker RK, Derman A, Heiberger C, Qureshi N, Amrutiya V, Atoot A, Dave M, Tabibian JH. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol. 2020 Aug 12;11(5):104-113. doi:10.4291/wjgp.v11.i5.104. PMID:32832194.

Buttó LF, Pelletier A, More SK, Zhao N, Osme A, Hager CL, Ghannoum MA, Sekaly RP, Cominelli F, Dave M. Intestinal Stem Cell Niche Defects Result in Impaired 3D Organoid Formation in Mouse Models of Crohn's Disease-like Ileitis. Stem Cell Reports. 2020 Aug 11;15(2):389-407. doi:10.1016/j.stemcr.2020.06.017. Epub 2020 Jul 16. PMID:32679063.

Luther J, Dave M. Rising Inflammatory Bowel Disease Prevalence Highlights the Need for Effective, Cost-Effective Therapies. Inflamm Bowel Dis. 2020 Mar 4;26(4):626-627. doi:10.1093/ibd/izz203. PMID:31854449.

Sheriff MZ, Mansoor E, Luther J, Ananthakrishnan AN, Abou Saleh M, Ho E, Briggs FBS, Dave M. Opportunistic Infections Are More Prevalent in Crohn's Disease and Ulcerative Colitis: A Large Population-Based Study. Inflamm Bowel Dis. 2020 Jan 6;26(2):291-300. doi:10.1093/ibd/izz147. PMID:31314891.

Gomez-Nguyen A, Ogbu N Jr, Cominelli F, Dave M. The "I" in Depression: How Feeding the Immune System Can Lead to Behavioral Changes in Inflammatory Conditions. Gastroenterology. 2018 Oct;155(4):1265-1267. doi:10.1053/j.gastro.2018.09.018. Epub 2018 Sep 11. PMID:30217741.

Mehta K, Jaiswal P, Briggs F, Faubion WA, Tabibian JH, Cominelli F, Dave M. In-patient outcomes of Hematopoietic Stem Cell Transplantation in Patients with Immune Mediated Inflammatory Diseases: A Nationwide Study. Sci Rep. 2018 May 1;8(1):6825. doi:10.1038/s41598-018-24060-4. PMID:29717163.

Luther J, Gala M, Patel SJ, Dave M, Borren N, Xavier RJ, Ananthakrishnan AN. Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways. Dig Dis Sci. 2018 Mar;63(3):738-745. doi:10.1007/s10620-018-4932-8. Epub 2018 Jan 25. PMID:29372477.

Dave M, Menghini P, Sugi K, Somoza RA, Lee Z, Jain M, Caplan A, Cominelli F. Ultrasound-guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases. J Vis Exp. 2017 Sep 1;(127):55367. doi:10.3791/55367. PMID:28892033.

Cohn HM, Dave M, Loftus EV Jr. Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017 Aug;23(8):1301-1315. doi:10.1097/MIB.0000000000001199. PMID:28708806.

Dave M. TSP-1-Mediated Induction of T Regulatory Cell by Adipose-Derived Mesenchymal Stem Cells: A Mechanism of Immunosuppression. Dig Dis Sci. 2017 Aug;62(8):1975-1976. doi:10.1007/s10620-017-4645-4. Epub 2017 Jun 12. PMID:28608047.